Zom­bie biotech Eleven Bio sheds staff in the fi­nal wind down

Ham­mered by back-to-back piv­otal tri­al fail­ures, Eleven Bio­ther­a­peu­tics ($EBIO) is con­tin­u­ing to wind down its op­er­a­tions. The biotech not­ed that it whacked 14 staffers last …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER